Roche
Franz Humer, former Chairman and CEO of Roche, has joined the board of Portuguese drug developer Bial.
Humer retired from Roche last year, following a career that saw him rise from Head of Pharmaceuticals and Chief Operating Officer at Hoffman-La Roche to CEO of Roche Group and Chairman of Roche Holding.
He has also held management positions at Schering-Plough and GSK, chaired drinks company Diageo and currently heads the board of the International Centre for Missing and Exploited Children.
Bial, which employs around 650 staff, said Humer’s addition to the board as a non-executive member is part of “the consolidation of BIAL’s internationalization strategy for the next decade.”
Humer said he has been following Bial for several years, “and I think it has made a remarkable journey, based on a long-term strategy focused on research and development, which is pioneer[ing] work in Portugal. I’m really excited to give my contribution to its strengthening, particularly in the international markets."